Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization:: Comparison of planned periodic chemoembolization and chemoembolization based on tumor response

被引:98
作者
Ernst, O
Sergent, G
Mizrahi, D
Delemazure, O
Paris, JC
L'Herminé, C
机构
[1] CHU Lille, Dept Radiol, F-59037 Lille, France
[2] CHU Lille, Dept Gastroenterol, F-59037 Lille, France
关键词
D O I
10.2214/ajr.172.1.9888740
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The purpose of our study was to assess the efficacy of transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma using two different infusion schedules. MATERIALS AND METHODS. Chemoembolization with lipiodol-mediated injection of doxorubicin was performed in 160 patients. In the first group of 80 patients, conventional chemoembolization was initially planned to be repeated at least three times at 2-month intervals. In the second group of 80 patients, chemoembolization was used selectively and repeated only when necessary on the basis of follow-up CT or MR imaging. According to the Okuda classification, 72 patients were stage 1, 33 belonging to group 1 (subgroup 1, Okuda I) and 39 belonging to group 2 (subgroup 2, Okuda 1). Eighty-eight patients were stage 2, 47 belonging to group 1 (subgroup 1, Okuda 2) and 41 belonging to group 2 (subgroup 2, Okuda 2). RESULTS. Complications of transcatheter arterial chemoembolization occurred in 19 patients from group 1 and six patients from group 2 (p < .001). The mean time between the first and the third courses was significantly different between group 1 (4 months) and group 2 (14 months) (p < .001). The 1-year, 2-year, and 3-year survival rates were significantly different between subgroup 1, Okuda 1, (58%, 28%, 11%) and subgroup 2, Okuda 1 (89%, 68%, 39%) (p < . 001), and between subgroup 1, Okuda 2 (19%, 0%, 0%), and subgroup 2, Okuda 2 (48%, 31%, 15%) (p < .001). CONCLUSION. The efficacy and tolerability of chemoembolization increase when it is used selectively and repeated only when necessary. Such technical considerations might explain some of the discrepancies of the results of chemoembolization in published data.
引用
收藏
页码:59 / 64
页数:6
相关论文
共 25 条
[1]   PRIMARY-TREATMENT OF HEPATOCELLULAR-CARCINOMA BY ARTERIAL CHEMOEMBOLIZATION [J].
BISMUTH, H ;
MORINO, M ;
SHERLOCK, D ;
CASTAING, D ;
MIGLIETTA, C ;
CAUQUIL, P ;
ROCHE, A .
AMERICAN JOURNAL OF SURGERY, 1992, 163 (04) :387-394
[2]   Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma [J].
Bronowicki, JP ;
Boudjema, K ;
Chone, L ;
Nisand, G ;
Bazin, C ;
Pflumio, F ;
Uhl, G ;
Wenger, JJ ;
Jaeck, D ;
Boissel, P ;
Bigard, MA ;
Gaucher, P ;
Vetter, D ;
Doffoel, M .
JOURNAL OF HEPATOLOGY, 1996, 24 (03) :293-300
[3]   THERAPEUTIC EFFECT OF TRANSCATHETER OILY CHEMOEMBOLIZATION THERAPY FOR ENCAPSULATED NODULAR HEPATOCELLULAR-CARCINOMA - CT AND PATHOLOGICAL FINDINGS [J].
CHOI, BI ;
KIM, HC ;
HAN, JK ;
PARK, JH ;
KIM, YI ;
KIM, ST ;
LEE, HS ;
KIM, CY ;
HAN, MC .
RADIOLOGY, 1992, 182 (03) :709-713
[4]   Treatment of hepatocellular carcinoma: A single-center experience [J].
Florio, F ;
Nardella, M ;
Balzano, S ;
Caturelli, E ;
Siena, D ;
Cammisa, M .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 1997, 20 (01) :23-28
[5]   UNRESECTABLE HEPATOCELLULAR-CARCINOMA - ANALYSIS OF PROGNOSTIC FACTORS IN TRANSCATHETER MANAGEMENT [J].
HATANAKA, Y ;
YAMASHITA, Y ;
TAKAHASHI, M ;
KOGA, Y ;
SAITO, R ;
NAKASHIMA, K ;
URATA, J ;
MIYAO, M .
RADIOLOGY, 1995, 195 (03) :747-752
[6]   A 5-YEAR EXPERIENCE OF LIPIODOLIZATION - SELECTIVE REGIONAL CHEMOTHERAPY FOR 200 PATIENTS WITH HEPATOCELLULAR-CARCINOMA [J].
KANEMATSU, T ;
FURUTA, T ;
TAKENAKA, K ;
MATSUMATA, T ;
YOSHIDA, Y ;
NISHIZAKI, T ;
HASUO, K ;
SUGIMACHI, K .
HEPATOLOGY, 1989, 10 (01) :98-102
[7]   TREATMENT OF HEPATOCELLULAR-CARCINOMA BY TRANSCATHETER ARTERIAL EMBOLIZATION COMBINED WITH INTRAARTERIAL INFUSION OF A MIXTURE OF CISPLATIN AND ETHIODIZED OIL [J].
KASUGAI, H ;
KOJIMA, J ;
TATSUTA, M ;
OKUDA, S ;
SASAKI, Y ;
IMAOKA, S ;
FUJITA, M ;
ISHIGURO, S .
GASTROENTEROLOGY, 1989, 97 (04) :965-971
[8]   SMALL HEPATOCELLULAR-CARCINOMA - TREATMENT WITH SUBSEGMENTAL TRANSCATHETER ARTERIAL EMBOLIZATION [J].
MATSUI, O ;
KADOYA, M ;
YOSHIKAWA, J ;
GABATA, T ;
ARAI, K ;
DEMACHI, H ;
MIYAYAMA, S ;
TAKASHIMA, T ;
UNOURA, M ;
KOGAYASHI, K .
RADIOLOGY, 1993, 188 (01) :79-83
[9]  
MONDAZZI L, 1994, HEPATOLOGY, V19, P1115, DOI 10.1016/0270-9139(94)90857-5
[10]   TRANSCATHETER OILY CHEMOEMBOLIZATION OF HEPATOCELLULAR-CARCINOMA [J].
NAKAMURA, H ;
HASHIMOTO, T ;
OI, H ;
SAWADA, S .
RADIOLOGY, 1989, 170 (03) :783-786